All patients were concurrently assessed for NRAS and KRAS codon 12 and 13 mutations; one ALL patient had a concurrent KRAS mutation with FLT3 but no other patients were concurrent for these mutations (Table 1). The gene discussed is KRAS; the disease is acute lymphoblastic leukemia.